Search

Your search keyword '"Antonino, Lasco"' showing total 2 results
Start Over Author "Antonino, Lasco" Publisher bioscientifica
2 results on '"Antonino, Lasco"'

1. Switch from tablet to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia in thyroxine-replaced postmenopausal women under simultaneous calcium supplementation

Author

Nunziata Morabito, Antonino Lasco, Elisabetta Morini, Salvatore Benvenga, and Antonino Catalano

Subjects
medicine.medical_specialty, Endocrinology, Blood pressure, Postmenopausal women, Calcium supplementation, business.industry, Internal medicine, Medicine, Capsule, business, Softgel, medicine.drug
Published
2019

2. Disappearance of a virilizing adrenal tumor following therapy with cyproterone acetate

Author

A Campennì, Elisabetta Morini, Antonino Lasco, Salvatore Benvenga, and D Maglitto

Subjects
Cancer Research, medicine.medical_specialty, medicine.drug_class, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Iatrogenic Disease, Adrenal Gland Neoplasms, Antineoplastic Agents, Antiandrogen, chemistry.chemical_compound, Endocrinology, Prednisone, Internal medicine, medicine, Humans, Cyproterone Acetate, Testosterone, Dexamethasone, business.industry, Virilization, WOMEN, Cyproterone acetate, Androgen Antagonists, Middle Aged, Virilism, Treatment Outcome, Oncology, chemistry, CYCLOSPORINE, CELLS, WOMEN, Nandrolone, CELLS, CYCLOSPORINE, Female, medicine.symptom, Tomography, X-Ray Computed, business, Anabolic steroid, medicine.drug
Abstract

A 57-year-old woman presented with an apparently obvious diagnosis of iatrogenic virilization. At the age of 51, she began a 4-year treatment with prednisone or cyclosporine, which are known to promote hair growth, for Behçet disease. At the age of 56, osteoporosis was overtreated with the anabolic steroid nandrolone. Insignificant inhibition by dexamethasone of the extremely high serum concentrations of testosterone and less high concentrations of weak androgens prompted us to search for a virilizing tumor. Computed tomography showed a 2.3 × 1.5 cm nodule in the right adrenal gland. As the patient refused surgery, virilization was treated with the antiandrogen cyproterone acetate (CPA), but for only 4 months because clinical and hormone abnormalities reversed and the tumor was no longer visible. The patient remains symptom-free. This first report of a curative effect of CPA on a purely virilizing adrenal tumor opens new avenues in the management of such tumors.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results